Nu Skin Enterprises, Inc.
NUS
$7.37
-$0.07-0.94%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 20,271.67% | -595.81% | 122.47% | -539.75% | -104.69% |
| Total Depreciation and Amortization | -22.95% | -11.49% | 5.03% | -6.68% | 20.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -687.95% | 297.12% | -88.45% | 520.33% | 13.64% |
| Change in Net Operating Assets | 41.25% | -46.91% | -55.40% | 88.70% | 50.03% |
| Cash from Operations | -88.28% | -52.40% | -38.40% | 44.16% | 115.03% |
| Capital Expenditure | -10.61% | 38.27% | 27.80% | 44.79% | -6.91% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -53.53% | -120.83% | -- | 20.62% | 194.08% |
| Cash from Investing | 2,060.10% | 11.53% | 45.01% | 90.78% | 36.98% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -648.72% | -4,873.53% | -598.12% | -722.43% | -509.17% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -226.49% | 67.22% | 99.59% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.77% | 84.52% | 84.69% | 84.69% | 84.64% |
| Other Financing Activities | 76.22% | -- | -- | -- | -- |
| Cash from Financing | -420.40% | -115.28% | 25.01% | -142.38% | -2,415.58% |
| Foreign Exchange rate Adjustments | 122.20% | -321.87% | 347.54% | 60.33% | -1,023.81% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 138.80% | -279.69% | 256.29% | 108.77% | -25.13% |